It covers the Meningioma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Meningioma pipeline therapeutics assessment by product type, stage ...

Blue Earth Therapeutics has an emerging pipeline initially focused on prostate cancer. For more information, please visit: https://www.blueearththerapeutics.com. About Bracco Imaging Bracco ...

According to the company, the proceeds will fund the advancement of its pipeline, including Nav1.8 inhibitors, which are in development as a non-opioid pain treatment. Financing was led by Blue Owl ...

as well as the development of Latigo's broader pipeline. The financing was led by funds managed by Blue Owl Capital, with participation from Deep Track Capital, Access Biotechnology, Qatar ...

The financing was led by funds managed by Blue Owl Capital, with participation from Deep Track Capital, Access Biotechnology, Qatar Investment Authority, Cormorant Asset Management, Sanofi Ventures, ...

On Thursday, HC Wainwright downgraded LAVA Therapeutics to Neutral from Buy with a price target of $1.50, citing pipeline overhang despite substantial cash reserve. Analyst Arthur He writes ...

On Tuesday, Coya Therapeutics, Inc. (NASDAQ:COYA) announced the expansion of its investigational pipeline and advancement of COYA 303 for inflammatory diseases. COYA 303 is an investigational ...

emphasizing the advancement of its precision therapeutics pipeline, with a particular focus on oncology. The company is progressing multiple high-value assets into the clinic, including selective ...

Weiss’ new startup, Marea Therapeutics, officially joined the ... Marea also has a number of unnamed programs in its pipeline. The startup was incubated by longtime biotech investor Third Rock ...